The Swiss drug maker said the Elecsys Anti-Sars-CoV-2 immunoassay is an in-vitro test to detect antibodies and assess the body’s immune reaction to Sars-CoV-2, better known as Covid-19, using human serum and plasma from a blood sample.

from MarketWatch.com - Top Stories https://ift.tt/3etLYSN
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/3etLYSN
via IFTTT
Kommentare
Kommentar veröffentlichen